Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata

BACKGROUND. Alopecia areata (AA) is an autoimmune disease characterized by hair loss mediated by CD8(+) T cells. There are no reliably effective therapies for AA. Based on recent developments in the understanding of the pathomechanism of AA, JAK inhibitors appear to be a therapeutic option; however,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JCI Insight
Asıl Yazarlar: Kennedy Crispin, Milène, Ko, Justin M., Craiglow, Brittany G., Li, Shufeng, Shankar, Gautam, Urban, Jennifer R., Chen, James C., Cerise, Jane E., Jabbari, Ali, Winge, Mårten C.G., Marinkovich, M. Peter, Christiano, Angela M., Oro, Anthony E., King, Brett A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2016
Konular:
Clinical Medicine
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5033755/
https://ncbi.nlm.nih.gov/pubmed/27699252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.89776
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller